A detailed history of Gould Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gould Capital, LLC holds 100 shares of BMY stock, worth $6,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 101 0.99%
Holding current value
$6,028
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 21, 2025

SELL
$51.92 - $59.94 $51 - $59
-1 Reduced 0.99%
100 $5,000
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $39 - $51
1 Added 1.0%
101 $5,000
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $4,798 - $5,440
100 New
100 $5,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $128B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gould Capital, LLC Portfolio

Follow Gould Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gould Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gould Capital, LLC with notifications on news.